Fertility Tourism Market Size, Share and Growth Outlook, 2026

Fertility Tourism Market Snapshot: Market Size, CAGR, and Growth Outlook (2021 to 2034)

The global Fertility Tourism Market size is forecast to increase from $2.32 Billion in 2026 to $12.64 Billion in 2034 at a CAGR of 23.6% between 2026 and 2034.

The Fertility Tourism market report provides detailed analysis and outlook of Fertility Tourism segments including By Procedure Type (In-Vitro Fertilization, Intracytoplasmic Sperm Injection, Intrauterine Insemination, Surrogacy, Egg, Egg Freezing), By Service Provider (Fertility Clinics, Multi-Specialty Hospitals, Specialized Cryobanks, Medical Tourism Agencies), By Patient Category (Single Parents, Same-Sex Couples, Heterosexual Couples), By Age Group (18–34 Years, 35–44 Years, 45 Years and Above) across global and regional markets. Further, analysis and outlook across 21 countries in North America, Europe, Asia Pacific, Middle East, Africa, and South America are provided in the study.

Fertility Tourism Industry Overview

Cross-Border Reproductive Care Driving Global Patient Mobility

The fertility tourism industry continues to expand as individuals and couples increasingly travel internationally to access assisted reproductive technologies, fertility preservation services, donor programs, and surrogacy arrangements. Regulatory differences, treatment availability, cost considerations, and varying legal frameworks across countries remain key factors influencing patient decisions regarding cross-border reproductive care. As fertility treatments become more globally accessible, healthcare providers, policymakers, and regulatory organizations are working to establish clearer standards and legal protections for international patients navigating complex reproductive pathways.

Legal Frameworks Influencing International Fertility Travel

Government agencies are strengthening legal guidance surrounding international reproductive arrangements to address citizenship, parentage, and documentation challenges. The Bureau of Consular Affairs of the United States Department of State reinforced legal and consular guidance for intended parents participating in international gestational surrogacy programs. The policy emphasizes the requirement for a documented biological connection to at least one U.S. citizen parent for automatic citizenship acquisition at birth. Such regulatory clarification addresses a critical consideration for families pursuing fertility treatments and surrogacy arrangements across national borders and highlights the importance of legal compliance within fertility tourism pathways.

Standardization Supporting Global Reproductive Healthcare

International organizations are working to improve consistency and communication across fertility care systems. The International Committee for Monitoring Assisted Reproductive Technology, together with leading reproductive health organizations, released the fourth edition of the International Glossary on Infertility and Fertility Care. The updated framework introduces numerous new definitions and revisions designed to standardize terminology related to infertility treatment, embryology, reproductive physiology, and cross-border reproductive care. Harmonized terminology facilitates clearer communication among clinicians, policymakers, regulators, and patients while supporting international collaboration within the fertility tourism ecosystem.

Regulatory Differences Shaping Emerging Fertility Destinations

Research continues to demonstrate the significant influence of national regulations on global fertility travel patterns. A multi-country policy analysis published in the Journal of IVF Worldwide examined fertility care dynamics across countries including the United States, United Kingdom, India, France, Israel, Japan, China, Ghana, and Italy. The study highlighted how evolving regulations concerning preimplantation genetic testing, embryo storage, and surrogacy access continue to redirect patient flows toward alternative treatment destinations. In parallel, a strategic assessment published in Frontiers identified South Africa as a growing fertility tourism destination due to its diverse donor availability and competitive treatment costs compared with North American and European markets. Industry stakeholders are advocating for regulatory modernization, strengthened donor oversight, and expanded access to cost-effective in vitro fertilization protocols to enhance the country's position within the global fertility tourism landscape.

Fertility Tourism Market Trends, Growth Drivers, Competitive Landscape, and Future Opportunities

The global Fertility Tourism market is witnessing increasing investments in innovation, product development, digital transformation, artificial intelligence integration, healthcare infrastructure expansion, and strategic partnerships across developed and emerging economies. Key Companies in the industry include- IVI-RMA Global, Create Fertility, IVF Spain, Reprofit International, Clinica Tambre, New Life Global, Gynem Fertility Centre, Nadezhda Women's Health Hospital, Ferticentro, Dunya IVF. The Fertility Tourism market is expected to remain one of the most closely watched segments in the global healthcare industry, with companies focusing on niche market segments. As healthcare systems across the US, Europe, Asia-Pacific, Latin America, and Middle East & Africa continue to prioritize efficiency, access, and innovation, the Fertility Tourism industry outlook remains shaped by rising healthcare expenditure, demographic change, digital transformation, and product innovation.
The report provides detailed market analysis including-

• Growth Fertility Tourism Market size outlook across 3 scenarios- High growth, reference, and Low growth cases

• Market Trends, Drivers, Potential Opportunities, and Challenges faced by Fertility Tourism companies

• Porter’s Five forces analysis- Bargaining power of buyers and sellers, Threat of Substitutes and new entrants, and Intensity of competitive rivalry

• Detailed SWOT Analysis of global and regional Fertility Tourism markets

• Competitive analysis including business description, product analysis, and financial profiles

• Key country specific analysis detailing key factors shaping the short-term and long-term outlook

• Recent industry developments and news including mergers, acquisitions, product launches, expansions, and company announcements

Fertility Tourism Market Competitive Benchmarking and Company Analysis

Leading companies in Fertility Tourism industry include- IVI-RMA Global, Create Fertility, IVF Spain, Reprofit International, Clinica Tambre, New Life Global, Gynem Fertility Centre, Nadezhda Women's Health Hospital, Ferticentro, Dunya IVF. The Fertility Tourism market remains moderately to highly fragmented, with competition expected to intensify as companies accelerate investments in innovation, geographic expansion, strategic partnerships, and portfolio diversification through 2034. In developed markets such as the United States, Germany, France, the United Kingdom, and Canada, competition is increasingly centered on innovation, reimbursement positioning, and value-based healthcare solutions. Meanwhile, emerging markets including China, India, Brazil, and countries across the Middle East and Africa continue to present significant opportunities for expansion due to rising healthcare expenditure, growing patient populations, and increasing access to healthcare services.

What to expect in US Fertility Tourism Markets in 2026 and beyond- Market Size, Share, Growth Rate, and Forecast to 2034

The US healthcare expenditure is forecast to reach $8.2 Trillion in 2034 from $5.5 Trillion in 2026 based on the National Health Expenditure Accounts (NHEA) data. With an aging population, rising chronic disease burden, and increasing migration toward minimally invasive and outpatient care, the Fertility Tourism market remains one of the strongest-performing segments in the country.
The US Fertility Tourism Companies are opting new business models, optimized pricing models, industry partnerships, and AI-enabled back end transformations to enhance efficiency and cost management. The US Fertility Tourism market faces successive waves of challenging trends, with strong opportunities across select segments. The CMS plan to implement Medicaid from 2027 is driving states to build eligibility verification systems throughout 2026. Looking ahead to 2034, we anticipate stronger results underpinned by opportunities exist across Fertility Tourism industry. On the medical device front, over 7,000 device manufacturers continue to gain from increasing demand from demand for implantable devices, surgical instruments, monitoring equipment, and diagnostic systems.

Canada- Proximity to the US and healthcare similarities to EU5 countries fuel sales of Canadian Fertility Tourism markets

Canada's strong Fertility Tourism sales performance is underpinned by an aging population and a well-developed healthcare infrastructure. Steady growth in new brand spending in rural and urban locations fuel the long-term prospects of small and medium-sized enterprises across medical, diagnostic, and therapeutic devices. The Canadian Fertility Tourism market presents significant opportunities for U.S. exporters of medical devices, with the U.S. being Canada’s largest trading partner for this sector. Potential advantages including specialized materials, advanced manufacturing techniques, and digital technologies support the launch of new products in the country.

Germany Fertility Tourism Trends and Perspectives to 2034- Financial sustainability, hospital restructuring, demographic pressures, and digitization of care delivery continue to shape the German healthcare industry.

Germany continues to remain the largest Fertility Tourism market in Europe, driven by over €600 Billion healthcare expenditure, €12 Billion medical device R&D expenditure, statutory health insurance system covering 90% German population, nationwide rollout of the electronic patient record (ePA), and large-volume of Fertility Tourism population. In particular, Research and development in Germany fuels the commercialization of cutting-edge technologies. Companies across the Germany Fertility Tourism industry value chain are focusing on both domestic markets and exports. The country is also driving digital adoption with the Hospital Future Act driving hospitals to upgrade their information systems by 2027. Over the forecast period, aging population, rising healthcare costs, and increasing procedural volumes drive the Fertility Tourism market outlook.

France Market Size, Growth Rate, and Forecast Analysis to 2034- Universal healthcare system, high public healthcare expenditure, and strong government support Fertility Tourism sales through 2034

France Fertility Tourism companies are emphasizing on opportunities for rapid, at-scale innovation to boost profitability over the long-term. The country’s National Health Insurance spending target (ONDAM) estimates 3.7% growth in the country’s healthcare expenditure. Over the forecast period, expenditure control measures, chronic disease management initiatives, workforce reforms, and efforts to improve system efficiency drive the long-term prospects.
The biggest 2026 policy frame is the PLFSS 2026. The law sets the Maladie branch spending target at €271.4 billion for 2026 and fixes the ONDAM at €117.5 billion for city care, €112.8 billion for health establishments, and €18.3 billion for elderly-care establishments and services. France’s market is also being pulled by demographics. INSEE estimates that on 1 January 2026 France had 69.1 million inhabitants, with 22% aged 65 or over. INSEE also reported that 2025 births were 645,000 and deaths were 651,000, producing a negative natural balance of about 6,000 for the first time since the end of the Second World War.

UK Fertility Tourism Market Size, Share, and Growth Projections to 2034- Rapid growth driven by new and existing brands across the industry value chain

Small high-need consumer segments remain key priority of Fertility Tourism distributors in the UK industry. Continuous launch of new products coupled with high expenditures support the market outlook. The UK Government financing remains the dominant funding source at 81.3% of total healthcare expenditure, or £280 billion in 2025. According to the ONS, total healthcare spending grew 7.7% nominally and 3.9% in real terms from 2024 to 2025. Similarly, out-of-pocket spending was £49 billion (14.1%) and voluntary health insurance was £9.5 billion (2.8%). The market is driven by rapid digital adoption with NHS England’s plan to give more than 500,000 staff access to new AI tools.

China Fertility Tourism Market Growth Drivers, Revenue Trends, and Forecast- Medical insurance coverage is rapidly expanding over the past few years

China Fertility Tourism market is undergoing a structural shift from hospital-centric care toward a more integrated system emphasizing primary care, outpatient services, and long-term care. Chinese local players are emerging as a strong pillar of Fertility Tourism industry, offering opportunities for both competition and partnership. Over the forecast period, new and innovative product launches remain key elements driving market outlook. China's healthcare industry is increasingly centered on expanding healthcare capacity, improving access to advanced treatments, and reducing dependence on imported technologies.
The National Healthcare Security Administration reported that by end-2024, China’s basic medical insurance covered 1.32662 billion people and the coverage rate was 95%. Regional disparities in consumer spending trends continue to become more pronounced in the Chinese Fertility Tourism industry. Over the forecast period, demand will keep shifting toward geriatrics, chronic disease management, rehabilitation, long-term care, and outpatient care, while pricing pressure will remain intense in drugs and consumables because reimbursement.

India Fertility Tourism Market Landscape: Current Size and Long-Term Growth Outlook - Increased pricing pressures in US market is encouraging domestic vendors to expand across India

Indian Fertility Tourism market is witnessing the rapid emergence of an ecosystem that brings together diverse companies across the industry value chain. Further, large-scale healthcare public and private investments and a steady growth in chronic conditions is driving sales of pharmaceuticals and medical devices. Further, non-retail channel is experiencing volume decrease and patients are migrating to the retail. Indian medical device firms are also combining precision engineering with lower labor costs to make world-class diagnostics, robotics, and critical care devices.

Brazil Fertility Tourism market remains price-driven, with products domestically manufactured and accessibility offering potential opportunities

Healthcare expenditure in Brazil exceeds 10% of GDP, with the country among the highest healthcare spenders in Latin America. ANS reported 53.2 million medical-plan beneficiaries in December 2025, while IBGE projects a steady rise in older-age cohorts, with people aged 60+ already representing about 23% of the population. The price sensitive market access is broad through the public system, private coverage adds a sizeable premium layer, and reimbursement, procurement, and hospital efficiency remain key buying drivers.

Middle East and Africa Fertility Tourism Industry Trends and Perspectives to 2034

According to the World Bank, the Middle East and North Africa population exceeds 500 million, while Sub-Saharan Africa's population exceeds 1.2 billion, making the broader MEA region one of the fastest-growing healthcare demand centers globally. The GCC countries including Saudi Arabia, United Arab Emirates, Qatar, and Kuwait continue to account for a disproportionately large share of regional healthcare spending. Government-led programs such as Saudi Arabia's Vision 2030 are accelerating investments in hospital infrastructure, private-sector participation, medical technology adoption, and healthcare digitalization. On the other hand, South Africa, Egypt, Nigeria, and Kenya remain key healthcare markets due to their large populations, expanding private healthcare sectors, and growing investments in healthcare delivery systems.

Fertility Tourism Market Segmentation

By Procedure Type
In-Vitro Fertilization
Intracytoplasmic Sperm Injection
Intrauterine Insemination
Surrogacy
Egg
Egg Freezing
By Service Provider
Fertility Clinics
Multi-Specialty Hospitals
Specialized Cryobanks
Medical Tourism Agencies
By Patient Category
Single Parents
Same-Sex Couples
Heterosexual Couples
By Age Group
18–34 Years
35–44 Years
45 Years and Above

Top Companies in Fertility Tourism Industry

IVI-RMA Global
Create Fertility
IVF Spain
Reprofit International
Clinica Tambre
New Life Global
Gynem Fertility Centre
Nadezhda Women's Health Hospital
Ferticentro
Dunya IVF

Countries Included

• North America- US, Canada, Mexico

• Europe- Germany, France, UK, Spain, Italy, Nordics, Others

• Asia Pacific- China, India, Japan, South Korea, Australia, Southeast Asia, Others

• Latin America- Brazil, Argentina, Others

• Middle East and Africa- Saudi Arabia, UAE, Other Middle East, South Africa, Other Africa

Latest Market Updates In Healthcare

Support this report with fresh, same-industry updates that strengthen topical depth and internal linking.

Market Update

Rise of Functional and Clinical-Grade Skincare

The rising geopolitical and tariff-related uncertainties, in particular, amidst United States’ renewed protectionist trade stance continues to driv...

June 2025